Evidence map›Paper›PMID 35451482›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2022

Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.

Nattawat Klomjit, Xiang-Yang Zhu, Alfonso Eirin, Aditya S Pawar, Sabena M Conley, Amrutesh S Puranik, Christopher M Ferguson, Seo Rin Kim, Hui Tang, Kyra L Jordan and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Nattawat KlomjitDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7648-2523
Xiang-Yang ZhuDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Alfonso EirinDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3864-9644
Aditya S PawarDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Sabena M ConleyDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Amrutesh S PuranikDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Christopher M FergusonDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Seo Rin KimDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Hui TangDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Kyra L JordanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Ishran M SaadiqDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Amir LermanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-9446-5313
Joseph P GrandeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA.
Stephen C TextorDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Lilach O LermanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3271-3887
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of Minnesota · US

Funding

Obesity-induced mesenchymal stem cell senescenceR01DK120292 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2019 to 2022
$2.6M
Quantitative magnetization transfer MRI for evaluation of renal fibrosisR01DK122734 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2020 to 2023
$2.2M
Noninvasive Evaluation of Renal Allograft Fibrosis by MRIR21AG062104 · NIA · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2020 to 2021
$414k
NIA NIH HHS R21 AG062104NIDDK NIH HHS R01 DK120292NIDDK NIH HHS R01 DK122734
6 · The paper itself

Abstract

backgroundRenal artery stenosis (RAS) is an important cause of chronic kidney disease and secondary hypertension. In animal models, renal ischemia leads to downregulation of growth factor expression and loss of intrarenal microcirculation. However, little is known about the sequelae of large-vessel occlusive disease on the microcirculation within human kidneys.

methodThis study included five patients who underwent nephrectomy due to renovascular occlusion and seven nonstenotic discarded donor kidneys (four deceased donors). Micro-computed tomography was performed to assess microvascular spatial densities and tortuosity, an index of microvascular immaturity. Renal protein expression, gene expression and histology were studied in vitro using immunoblotting, polymerase chain reaction and staining.

resultsRAS demonstrated a loss of medium-sized vessels (0.2-0.3 mm) compared with donor kidneys (P = 0.037) and increased microvascular tortuosity. RAS kidneys had greater protein expression of angiopoietin-1, hypoxia-inducible factor-1α and thrombospondin-1 but lower protein expression of vascular endothelial growth factor (VEGF) than donor kidneys. Renal fibrosis, loss of peritubular capillaries (PTCs) and pericyte detachment were greater in RAS, yet they had more newly formed PTCs than donor kidneys. Therefore, our study quantified significant microvascular remodeling in the poststenotic human kidney. RAS induced renal microvascular loss, vascular remodeling and fibrosis. Despite downregulated VEGF, stenotic kidneys upregulated compensatory angiogenic pathways related to angiopoietin-1.

conclusionsThese observations underscore the nature of human RAS as a microvascular disease distal to main vessel stenosis and support therapeutic strategies directly targeting the poststenotic kidney microcirculation in patients with RAS.

Indexed as

Renal Artery ObstructionAngiopoietin-1AnimalsFibrosisHumansHypoxia-Inducible Factor 1, alpha SubunitKidneyRenal CirculationThrombospondinsVascular Endothelial Growth Factor AX-Ray MicrotomographyAngiopoietin-1Hypoxia-Inducible Factor 1, alpha SubunitThrombospondinsVascular Endothelial Growth Factor Aangiogenesismicro-CTmicrovascular losspericyterenal artery stenosis

Identifiers

PMID35451482
PMCPMC9494086
OpenAlexW4224261948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.